← Open Payments lookup

DIANE SPEELMAN: Open Payments

NPI 1952637241 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,500 in 32 payments from 15 companies in 2025. Trend: 2023 $135 · 2024 $1,215 · 2025 $5,500

Food & beverage: $3,141Travel & lodging: $1,647Honoraria: $600Education: $112
CompanyPaymentsAmount
Pharmacosmos Therapeutics Inc.7$2,417
Janssen Biotech, Inc.4$546
Gilead Sciences, Inc.4$435
AstraZeneca Pharmaceuticals LP3$372
Astellas Pharma Global Development2$281
ABBVIE INC.2$225
JAZZ PHARMACEUTICALS INC.1$150
Daiichi Sankyo Inc.1$150
Novartis Pharmaceuticals Corporation2$146
American Regent1$145

Products named: MONOFERRIC, COSELA, RYBREVANT, INJECTAFER, ZIIHERA, Padcev, Xtandi, MI CANCER SEEK.

Industry payments across WA — which companies pay providers there.